Insights

John Rearick to Speak at Life Sciences Patent Network 2022

John Rearick will be presenting "Fully Exploiting Your Innovations: Best Practice in Innovation Harvesting," at the Life Sciences Patent Network on Wednesday, May 22, 2022.

Choate Elects Six to Partnership

Today Choate announced its largest class of new equity partners in the Firm’s history for the second year in a row.

John Rearick Reviews Patent Strategies in Light of Clinical Trial Disclosures

John Rearick is moderating the Life Sciences Patent Network Live 2021 panel, “Patent Strategies in Light of Clinical Trial Disclosures” on Tuesday, October 5 at 1:30 pm EST.

Conducting Clinical Trials Part 1: When Should You File Your Patent Applications?

As the first installment of Choate’s Conducting Clinical Trials series, Bryana McGillycuddy and John Rearick discuss a range of implications associated with the timing of filing, including the validity of the patent and the risk of inadvertent disclosure.

FORMA Therapeutics and the University of Oxford Announce Multi-Year Cross-Border Collaboration

Choate represented FORMA Therapeutics in its recent cross-border collaboration and license agreement with the University of Oxford.

Choate Promotes Four to Counsel

Four Choate attorneys – Mark DeFeo, Renat Lumpau, John Rearick, and Anita Spieth – have been named counsel at the Firm, effective May 1, 2017.

John Rearick Participates in a Career Series Panel at Harvard

John Rearick Speaks on Translational Research in Biomaterials at Boston University